5-Karboksamidotriptamin
Изглед
(преусмерено са 5-karboksamidotriptamin)
IUPAC ime | |
---|---|
3-(2-aminoethyl)-1H-indole-5-carboxamide | |
Identifikatori | |
CAS broj | 74885-09-9 |
ATC kod | None |
PubChem | CID 1809 |
IUPHAR/BPS | 4 |
ChemSpider | 1743 |
ChEMBL | CHEMBL18840 |
Hemijski podaci | |
Formula | C11H13N3O |
Molarna masa | 203.240 g/mol |
| |
|
5-Karboksamidotriptamin (5-CT) je triptaminski derivat koji je blisko srodan sa neurotransmiterom serotoninom.
5-CT deluje kao neselektivni pun agonist visokog afiniteta na 5-HT1A, 5-HT1B, 5-HT1D, 5-HT5A, i 5-HT7 receptore, kao i na 5-HT2, 5-HT3, 5-HT6 receptore sa nižim afinitetom.[1][2][3] On ima neznatan afinitet za 5-HT1E i 5-HT1F receptore.[4] 5-CT se najjače vezuje za 5-HT1A receptor i nekad se smatralo da je selektivan za njega.[5][6]
Vidi još
[уреди | уреди извор]- 2-Metil-5-hidroksitriptamin
- 5-Benziloksitriptamin
- 5-Metoksitriptamin
- α-Metil-5-hidroksitriptamin
- Sumatriptan
Референце
[уреди | уреди извор]- ^ Yamada J, Sugimoto Y, Noma T, Yoshikawa T (1998). „Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.”. Eur J Pharmacol. 359 (1): 81—86. PMID 9831297. doi:10.1016/S0014-2999(98)00617-7.
- ^ Wright, CE; Angus, JA (1989). „5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets.”. Journal of cardiovascular pharmacology. 13 (4): 557—64. PMID 2470992.
- ^ Glennon RA, Dukat M, Westkaemper RB (01. 01. 2000). „Serotonin Receptor Subtypes and Ligands”. American College of Neurophyscopharmacology. Приступљено 11. 04. 2008.
- ^ Stanton JA, Middlemiss DN, Beer MS (1996). „Autoradiographic localization of 5-CT-insensitive 5-HT1-like recognition sites in guinea pig and rat brain.”. Neuropharmacology. 35 (2): 223—229. PMID 8734492. doi:10.1016/0028-3908(95)00178-6.
- ^ Thomas, DR; Middlemiss, DN; Taylor, SG; Nelson, P; Brown, AM (1999). „5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.”. British journal of pharmacology. 128 (1): 158—64. PMC 1571602 . PMID 10498847. doi:10.1038/sj.bjp.0702759.
- ^ Saxena, PR; Lawang, A (1985). „A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.”. Archives internationales de pharmacodynamie et de therapie. 277 (2): 235—52. PMID 2933009.